Crossref
The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer
SECI Oncology · 2014
DOI: 10.18056/seci2014.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift SECI Oncology, 2014. Verfasst von Ashraf Zedan.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zedan, A. (2014). The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer. SECI Oncology. https://doi.org/10.18056/seci2014.10
Vancouver
Zedan A. The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer. SECI Oncology. 2014. doi:10.18056/seci2014.10
BibTeX
@article{Zedan2014,
author = {Zedan, Ashraf},
title = {The role of Circulating Tumor Cells (CTCs) in Predicting the Response of Primary (Neoadjuvant) Chemotherapy and its Impact as a Prognostic Factor in Early Breast Cancer},
journal = {SECI Oncology},
year = {2014},
doi = {10.18056/seci2014.10}
}
EUVIMED